FreeCME

Transformation of Chronic Lymphocytic Leukemia Diagnosis and Treatment

Transformation of Chronic Lymphocytic Leukemia Diagnosis and Treatment

This activity is provided by Imedex®, LLC.


Supported by educational grants from Pharmacyclics, an AbbView Company and Janssen Biotech, Inc. and TG Therapeutics..

Specialty: Hematology/Oncology, Oncology

Target Audience: This educational activity is designed for US-based hematologists, medical oncologists, hematopathologists, other healthcare professionals interested in the therapeutic management of hematologic malignancies.

Credit Available

  • Physicians — maximum of 0.75 AMA PRA Category 1 Credit(s)

All other health care professionals completing this course will be issued a statement of participation.

This series consists of 2 continuing education activities, the links below will be live and take you to activity details and content.

 

Module 1 – Velocity Vlog: Transforming the Diagnosis and Treatment of Chronic Lymphocytic Leukemia

 

Module 2 – Whiteboard Update: Transforming the Diagnosis and Treatment of Chronic Lymphocytic Leukemia